An overview of GLP-1 agonists and recent cardiovascular outcomes trials
Combining results from the seven individual studies into a statistically powerful dataset, on the other hand, allows an attempt to extract information that is both highly relevant and widely applicable
However, as trials are still underway, there is currently no approved dose of retatrutide
De Filippis B, Valenti D, de Bari L, De Rasmo D, Musto M, Fabbri A, et al
Clinical trials show constipation occurs in approximately 11-24% of patients taking semaglutide and 6-11% taking tirzepatide, compared to 11% in placebo groups
For a 200-pound person, that represents 44 pounds lost